# Lithium Carbonate

NDC: 0054-0021
Generic name: Lithium Carbonate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20041028

FDA application: ANDA076832

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0021"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0021
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c612b6c5-eeb9-4fdd-8c85-bb3d2147cd1e